American Society Nuclear Cardiology (ASNC)

The American Society of Nuclear Cardiology (ASNC) is the international leader in education, government policy advocacy, guidelines and quality in cardiovascular nuclear imaging. Cardiac SPECT remains the workhorse molecular imaging modality for myocardial perfusion imaging (MPI), but cardiac PET is gaining ground because of its advantages in much shorter exam times and the ability to offer additional information the function of the heart.

RSS icon
Video interview with ASNC President President Mouaz Al-Mallah, MD, who explains why nuclear cardiology needs to upgrade its technology to be competitive. #ASNC #ASNC2023 #ASNC23

Previewing ASNC 2023: Why nuclear cardiology needs to evolve

ASNC President President Mouaz Al-Mallah, MD, said nuclear cardiology needs to upgrade old imaging systems and embrace new technology to deliver better value for patients. 

September 19, 2023
VIDEO: American Society of Nuclear Cardiology (ASNC) President Mouaz Al-Mallah, MD, chair of cardiovascular PET and associate director of nuclear cardiology, Houston Methodist DeBakey Heart and Vascular Center, and ASNC President-elect Larry Phillips, MD, director of nuclear cardiology, NYU Langone, outline the new technologies available and why upgrading cardiac nuclear labs matters and what is the ROI. #ASNC

What is the ROI for upgrading nuclear cardiology labs?

Some nuclear cardiology labs are still using SPECT systems that are 20-25 years old. Is it time to make an upgrade? 

April 12, 2023
Cardiac SPECT nuclear imaging myocardial perfusion_Spectrum Dynamics_RSNA22_DF_3.jpeg

ASNC 2023 president calls for nuclear cardiology to embrace new technology

American Society of Nuclear Cardiology (ASNC) 2023 President Mouaz H. Al-Mallah, MD, said the subspecialty needs to up its game with new technology.

January 3, 2023
Barry L. Zaret, MD

Veteran cardiologist, viewed by many as the founder of nuclear cardiology, dies at 82

Barry L. Zaret, MD, was an influential cardiologist, accomplished poet and veteran of the United States Air Force. 

October 28, 2022
Comparison of flurpiridaz F-18 PET, SPECT and angiography of the 60-year-old female patients in the Aurora trial. The SPECT scan appeared normal, but flurpiridaz was shown to be more sensitive and showed the ischemia from two blockages in the right coronary artery. The new radiotracer may help expand cardiac PET. #ASNC

Flurpiridaz data shows promise to expand and enhance cardiac PET

The biggest news from the American Society of Nuclear Cardiology (ASNC) 2022 meeting was positive late-breaking data on the phase 3 Aurora trial for the flurpiridaz (F-18) PET radiotracer agent.

September 12, 2022
A cardiac CT scan being performed at Duly Healthcare in suburban Chicago in the spring of 2022. This is one of the first outpatient cardiology clinics in the U.S. to implement a CCTA program for screening non-acute chest pain patients and for structural heart evaluations. This applies to CCTA, CTA, Cardiac CT, and CT angiography and coronary CT angiography.

Cardiac CT now in the spotlight thanks to chest pain guidelines

With the elevation of cardiac CT to a 1A indication in the 2021 Chest Pain Guidelines, there has been a large amount of interest in starting coronary artery CT angiography (CCTA) programs. 

August 3, 2022
health_insurance_family.png

Big private payer reverses course on cardiac PET/CT coverage

One of the largest private health insurers in the U.S. has gone from considering hybrid PET/CT for cardiac indications “experimental/investigational” to displaying willingness to pay for the modality. 

July 1, 2022
The American Medical Association (AMA) Board of Delegates approved a policy calling on payers to reimburse for the drug regadenoson and not to employ payment policies that push for cardiologists to change the drug they use for pharmacologic stress for one that is considered less safe. The policy was adopted at the AMA 2022 meeting. #AMA #AMA175 #AMAmtg #ASNC

AMA supports reimbursement for pharmacologic stress agent regadenoson

The American Medical Association Board of Delegates approved a policy calling on payers to reimburse for the drug regadenoson and not to employ payment policies that push for cardiologists to change the drug they use for pharmacologic stress for one that is considered less safe.

June 22, 2022
Displaying 9 - 16 of 39

Around the web

Cardiovascular Business
AI improves CT assessments, boosts care for real-world heart patients

Automated AI-generated measurements combined with annotated CT images can improve treatment planning and help referring physicians and patients better understand their disease, explained Sarah Jane Rinehart, MD, director of cardiac imaging with Charleston Area Medical Center.

Cardiovascular Business
AI predicts cardiovascular risk during CT scans—no invasive tests or contrast required

Two advanced algorithms—one for CAC scores and another for segmenting cardiac chamber volumes—outperformed radiologists when assessing low-dose chest CT scans. 

Radiology Business
Google teams with Bayer to address radiologist burnout via AI

"Gen AI can help tackle repetitive tasks and provide insights into massive datasets, saving valuable time," Thomas Kurian, CEO of Google Cloud, said Tuesday. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup